A vaccine used to prevent cervical cancer caused by human papillomavirus (HPV) types 16 and 18. Cervarix is approved for use in females aged 9 to 25 years. It is a type of bivalent vaccine (a vaccine that works against two different viruses or other microorganisms). Also called recombinant human papillomavirus bivalent vaccine.